Robotics is rapidly advancing beyond the operating room into patient recovery. Devices paired with brain–computer interfaces and adaptive machine learning algorithms are helping stroke and spinal cord injury patients regain movement faster than ever before. In this episode, Owen Kent and Todd Roberts, Founders of ATDev, highlight the latest neurorobotic systems, their impact on neural plasticity, and the promise of personalized rehabilitation programs.

In this episode, we’re exploring how wearables are improving drug delivery. Matt Huddleston, chief commercial officer and executive vice president of Enable Injections talk with us about how these wearables are enabling personalized drug delivery, ultimately improving quality of life for patients with chronic conditions.

In today’s episode, we’re exploring the growing emphasis on sustainability in drug-delivery devices. Martin Alexander Sørensen, Mechanical Design Engineer, and Martin Høier Thomsen, Senior Development Engineer and Project Manager, at MGS discuss the challenges and opportunities in developing greener drug-delivery solutions without compromising performance or safety.

In this episode, we’re exploring how targeted intra-arterial delivery platforms are redefining the treatment of solid tumors, offering a way to bathe cancer directly in therapy while limiting systemic toxicity. Our guest is Shaun Bagai, CEO of RenovoRx, who will discuss an ongoing post-marketing registry study that is gathering real-world evidence on safety, performance, and survival outcomes for patients receiving these localized treatments.

In this episode, we’re diving into personalized medicine and drug delivery — and how cutting-edge tools like AI, automation,and robotics are transforming cancer care. Joining us in this episode is Jim Foote, Co-founder and CEO of First Ascent Biomedical. First Ascent is at the forefront of developing platforms that personalize therapy by leveraging advanced analytics and automation — with the goal of reducing trial-and-error in oncology and improving patient outcomes.

This episode delves into some of the latest advancements in materials for medical devices. Dr. Jeremy Schaffer, Head of R&D at Fort Wayne Metals, talks to us about how new materials are enabling the production of devices that are stronger, more flexible, and more sustainable.

This episode investigates how advanced manufacturing using techniques such as automation and artificial intelligence is streamlining production processes in the medical device industry. Francisco Almada Lobo, CEO of Critical Manufacturing, dives into how AI-driven quality control, predictive maintenance, and process optimization are improving efficiency and reducing manufacturing costs.

In our continuing look at advanced manufacturing in healthcare, this episode explores how 3D printing is transforming the design and production of medical devices. My guest today is Atul Dhall, Engineering Consultant at TransAtlantic Science. He will talk to us about the benefits of creating custom implants, prosthetics, and surgical tools tailored to individual patients, as well as the ability to quickly prototype new devices for testing and development.

In this season, as we look at the advanced manufacturing in healthcare, this episode addresses one of the most pressing challenges in medical device manufacturing: ensuringsafety when materials or processes change — because how even small material modifications can impact biocompatibility and regulatory compliance. Audrey Turley, Director of Lab Operations, Biosafety, Nelson Laboratories providespractical strategies for assessing risk, streamlining testing, and managing documentation.

This episode explores how wearables are being used to detect early signs of health issues. Dr. Shalini Prasad, professor of bioengineering at the University of Texas at Dallas, discusses her work, which focuses on using sweat and other biomarkers to detect early signs of disease, paving the way for wearable devices that can transform preventative healthcare.